STAT+: Pharmalittle: FTC may sue to block Amgen deal for Horizon; Supreme Court declines Teva appeal on skinny labeling

The FTC is expected to file a lawsuit to block Amgen from acquiring Horizon Therapeutics, arguing the $27.8 billion deal would hamper innovation.